Global Translational Regenerative Medicine Supply, Demand and Key Producers, 2023-2029

Global Translational Regenerative Medicine Supply, Demand and Key Producers, 2023-2029

Page: 110

Published Date: 26 Mar 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

This report studies the global Translational Regenerative Medicine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Translational Regenerative Medicine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Translational Regenerative Medicine that contribute to its increasing demand across many markets.

The global Translational Regenerative Medicine market size is expected to reach $ 29460 million by 2029, rising at a market growth of 12.9% CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Translational Regenerative Medicine total production and demand, 2018-2029, (K Units)
Global Translational Regenerative Medicine total production value, 2018-2029, (USD Million)
Global Translational Regenerative Medicine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Translational Regenerative Medicine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Translational Regenerative Medicine domestic production, consumption, key domestic manufacturers and share
Global Translational Regenerative Medicine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Translational Regenerative Medicine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Translational Regenerative Medicine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Translational Regenerative Medicine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Athersys, Avita Medical, AxoGen, MEDIPOST, NuVasive, Astellas Pharma, Organogenesis Holdings, Osiris Therapeutics and Pharmicell, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Translational Regenerative Medicine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Translational Regenerative Medicine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Translational Regenerative Medicine Market, Segmentation by Type
Stem Cell Therapy
Tissue Engineering
Gene Therapy

Global Translational Regenerative Medicine Market, Segmentation by Application
Tissue Engineering Therapy
Wound Healing
Cartilage Repair
Other

Companies Profiled:
Athersys
Avita Medical
AxoGen
MEDIPOST
NuVasive
Astellas Pharma
Organogenesis Holdings
Osiris Therapeutics
Pharmicell
Regenerys
Takeda Pharmaceutical
uniQure
Vericel

Key Questions Answered
1. How big is the global Translational Regenerative Medicine market?
2. What is the demand of the global Translational Regenerative Medicine market?
3. What is the year over year growth of the global Translational Regenerative Medicine market?
4. What is the production and production value of the global Translational Regenerative Medicine market?
5. Who are the key producers in the global Translational Regenerative Medicine market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Translational Regenerative Medicine Introduction
1.2 World Translational Regenerative Medicine Supply & Forecast
1.2.1 World Translational Regenerative Medicine Production Value (2018 & 2022 & 2029)
1.2.2 World Translational Regenerative Medicine Production (2018-2029)
1.2.3 World Translational Regenerative Medicine Pricing Trends (2018-2029)
1.3 World Translational Regenerative Medicine Production by Region (Based on Production Site)
1.3.1 World Translational Regenerative Medicine Production Value by Region (2018-2029)
1.3.2 World Translational Regenerative Medicine Production by Region (2018-2029)
1.3.3 World Translational Regenerative Medicine Average Price by Region (2018-2029)
1.3.4 North America Translational Regenerative Medicine Production (2018-2029)
1.3.5 Europe Translational Regenerative Medicine Production (2018-2029)
1.3.6 China Translational Regenerative Medicine Production (2018-2029)
1.3.7 Japan Translational Regenerative Medicine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Translational Regenerative Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Translational Regenerative Medicine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Translational Regenerative Medicine Demand (2018-2029)
2.2 World Translational Regenerative Medicine Consumption by Region
2.2.1 World Translational Regenerative Medicine Consumption by Region (2018-2023)
2.2.2 World Translational Regenerative Medicine Consumption Forecast by Region (2024-2029)
2.3 United States Translational Regenerative Medicine Consumption (2018-2029)
2.4 China Translational Regenerative Medicine Consumption (2018-2029)
2.5 Europe Translational Regenerative Medicine Consumption (2018-2029)
2.6 Japan Translational Regenerative Medicine Consumption (2018-2029)
2.7 South Korea Translational Regenerative Medicine Consumption (2018-2029)
2.8 ASEAN Translational Regenerative Medicine Consumption (2018-2029)
2.9 India Translational Regenerative Medicine Consumption (2018-2029)

3 World Translational Regenerative Medicine Manufacturers Competitive Analysis
3.1 World Translational Regenerative Medicine Production Value by Manufacturer (2018-2023)
3.2 World Translational Regenerative Medicine Production by Manufacturer (2018-2023)
3.3 World Translational Regenerative Medicine Average Price by Manufacturer (2018-2023)
3.4 Translational Regenerative Medicine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Translational Regenerative Medicine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Translational Regenerative Medicine in 2022
3.5.3 Global Concentration Ratios (CR8) for Translational Regenerative Medicine in 2022
3.6 Translational Regenerative Medicine Market: Overall Company Footprint Analysis
3.6.1 Translational Regenerative Medicine Market: Region Footprint
3.6.2 Translational Regenerative Medicine Market: Company Product Type Footprint
3.6.3 Translational Regenerative Medicine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Translational Regenerative Medicine Production Value Comparison
4.1.1 United States VS China: Translational Regenerative Medicine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Translational Regenerative Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Translational Regenerative Medicine Production Comparison
4.2.1 United States VS China: Translational Regenerative Medicine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Translational Regenerative Medicine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Translational Regenerative Medicine Consumption Comparison
4.3.1 United States VS China: Translational Regenerative Medicine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Translational Regenerative Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Translational Regenerative Medicine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Translational Regenerative Medicine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Translational Regenerative Medicine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Translational Regenerative Medicine Production (2018-2023)
4.5 China Based Translational Regenerative Medicine Manufacturers and Market Share
4.5.1 China Based Translational Regenerative Medicine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Translational Regenerative Medicine Production Value (2018-2023)
4.5.3 China Based Manufacturers Translational Regenerative Medicine Production (2018-2023)
4.6 Rest of World Based Translational Regenerative Medicine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Translational Regenerative Medicine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Translational Regenerative Medicine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Translational Regenerative Medicine Production (2018-2023)

5 Market Analysis by Type
5.1 World Translational Regenerative Medicine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Stem Cell Therapy
5.2.2 Tissue Engineering
5.2.3 Gene Therapy
5.3 Market Segment by Type
5.3.1 World Translational Regenerative Medicine Production by Type (2018-2029)
5.3.2 World Translational Regenerative Medicine Production Value by Type (2018-2029)
5.3.3 World Translational Regenerative Medicine Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Translational Regenerative Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Tissue Engineering Therapy
6.2.2 Wound Healing
6.2.3 Cartilage Repair
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Translational Regenerative Medicine Production by Application (2018-2029)
6.3.2 World Translational Regenerative Medicine Production Value by Application (2018-2029)
6.3.3 World Translational Regenerative Medicine Average Price by Application (2018-2029)

7 Company Profiles
7.1 Athersys
7.1.1 Athersys Details
7.1.2 Athersys Major Business
7.1.3 Athersys Translational Regenerative Medicine Product and Services
7.1.4 Athersys Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Athersys Recent Developments/Updates
7.1.6 Athersys Competitive Strengths & Weaknesses
7.2 Avita Medical
7.2.1 Avita Medical Details
7.2.2 Avita Medical Major Business
7.2.3 Avita Medical Translational Regenerative Medicine Product and Services
7.2.4 Avita Medical Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Avita Medical Recent Developments/Updates
7.2.6 Avita Medical Competitive Strengths & Weaknesses
7.3 AxoGen
7.3.1 AxoGen Details
7.3.2 AxoGen Major Business
7.3.3 AxoGen Translational Regenerative Medicine Product and Services
7.3.4 AxoGen Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 AxoGen Recent Developments/Updates
7.3.6 AxoGen Competitive Strengths & Weaknesses
7.4 MEDIPOST
7.4.1 MEDIPOST Details
7.4.2 MEDIPOST Major Business
7.4.3 MEDIPOST Translational Regenerative Medicine Product and Services
7.4.4 MEDIPOST Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 MEDIPOST Recent Developments/Updates
7.4.6 MEDIPOST Competitive Strengths & Weaknesses
7.5 NuVasive
7.5.1 NuVasive Details
7.5.2 NuVasive Major Business
7.5.3 NuVasive Translational Regenerative Medicine Product and Services
7.5.4 NuVasive Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 NuVasive Recent Developments/Updates
7.5.6 NuVasive Competitive Strengths & Weaknesses
7.6 Astellas Pharma
7.6.1 Astellas Pharma Details
7.6.2 Astellas Pharma Major Business
7.6.3 Astellas Pharma Translational Regenerative Medicine Product and Services
7.6.4 Astellas Pharma Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Astellas Pharma Recent Developments/Updates
7.6.6 Astellas Pharma Competitive Strengths & Weaknesses
7.7 Organogenesis Holdings
7.7.1 Organogenesis Holdings Details
7.7.2 Organogenesis Holdings Major Business
7.7.3 Organogenesis Holdings Translational Regenerative Medicine Product and Services
7.7.4 Organogenesis Holdings Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Organogenesis Holdings Recent Developments/Updates
7.7.6 Organogenesis Holdings Competitive Strengths & Weaknesses
7.8 Osiris Therapeutics
7.8.1 Osiris Therapeutics Details
7.8.2 Osiris Therapeutics Major Business
7.8.3 Osiris Therapeutics Translational Regenerative Medicine Product and Services
7.8.4 Osiris Therapeutics Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Osiris Therapeutics Recent Developments/Updates
7.8.6 Osiris Therapeutics Competitive Strengths & Weaknesses
7.9 Pharmicell
7.9.1 Pharmicell Details
7.9.2 Pharmicell Major Business
7.9.3 Pharmicell Translational Regenerative Medicine Product and Services
7.9.4 Pharmicell Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Pharmicell Recent Developments/Updates
7.9.6 Pharmicell Competitive Strengths & Weaknesses
7.10 Regenerys
7.10.1 Regenerys Details
7.10.2 Regenerys Major Business
7.10.3 Regenerys Translational Regenerative Medicine Product and Services
7.10.4 Regenerys Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Regenerys Recent Developments/Updates
7.10.6 Regenerys Competitive Strengths & Weaknesses
7.11 Takeda Pharmaceutical
7.11.1 Takeda Pharmaceutical Details
7.11.2 Takeda Pharmaceutical Major Business
7.11.3 Takeda Pharmaceutical Translational Regenerative Medicine Product and Services
7.11.4 Takeda Pharmaceutical Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Takeda Pharmaceutical Recent Developments/Updates
7.11.6 Takeda Pharmaceutical Competitive Strengths & Weaknesses
7.12 uniQure
7.12.1 uniQure Details
7.12.2 uniQure Major Business
7.12.3 uniQure Translational Regenerative Medicine Product and Services
7.12.4 uniQure Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 uniQure Recent Developments/Updates
7.12.6 uniQure Competitive Strengths & Weaknesses
7.13 Vericel
7.13.1 Vericel Details
7.13.2 Vericel Major Business
7.13.3 Vericel Translational Regenerative Medicine Product and Services
7.13.4 Vericel Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Vericel Recent Developments/Updates
7.13.6 Vericel Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Translational Regenerative Medicine Industry Chain
8.2 Translational Regenerative Medicine Upstream Analysis
8.2.1 Translational Regenerative Medicine Core Raw Materials
8.2.2 Main Manufacturers of Translational Regenerative Medicine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Translational Regenerative Medicine Production Mode
8.6 Translational Regenerative Medicine Procurement Model
8.7 Translational Regenerative Medicine Industry Sales Model and Sales Channels
8.7.1 Translational Regenerative Medicine Sales Model
8.7.2 Translational Regenerative Medicine Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Translational Regenerative Medicine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Translational Regenerative Medicine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Translational Regenerative Medicine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Translational Regenerative Medicine Production Value Market Share by Region (2018-2023)
Table 5. World Translational Regenerative Medicine Production Value Market Share by Region (2024-2029)
Table 6. World Translational Regenerative Medicine Production by Region (2018-2023) & (K Units)
Table 7. World Translational Regenerative Medicine Production by Region (2024-2029) & (K Units)
Table 8. World Translational Regenerative Medicine Production Market Share by Region (2018-2023)
Table 9. World Translational Regenerative Medicine Production Market Share by Region (2024-2029)
Table 10. World Translational Regenerative Medicine Average Price by Region (2018-2023) & (USD/Unit)
Table 11. World Translational Regenerative Medicine Average Price by Region (2024-2029) & (USD/Unit)
Table 12. Translational Regenerative Medicine Major Market Trends
Table 13. World Translational Regenerative Medicine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Translational Regenerative Medicine Consumption by Region (2018-2023) & (K Units)
Table 15. World Translational Regenerative Medicine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Translational Regenerative Medicine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Translational Regenerative Medicine Producers in 2022
Table 18. World Translational Regenerative Medicine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Translational Regenerative Medicine Producers in 2022
Table 20. World Translational Regenerative Medicine Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 21. Global Translational Regenerative Medicine Company Evaluation Quadrant
Table 22. World Translational Regenerative Medicine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Translational Regenerative Medicine Production Site of Key Manufacturer
Table 24. Translational Regenerative Medicine Market: Company Product Type Footprint
Table 25. Translational Regenerative Medicine Market: Company Product Application Footprint
Table 26. Translational Regenerative Medicine Competitive Factors
Table 27. Translational Regenerative Medicine New Entrant and Capacity Expansion Plans
Table 28. Translational Regenerative Medicine Mergers & Acquisitions Activity
Table 29. United States VS China Translational Regenerative Medicine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Translational Regenerative Medicine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Translational Regenerative Medicine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Translational Regenerative Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Translational Regenerative Medicine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Translational Regenerative Medicine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Translational Regenerative Medicine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Translational Regenerative Medicine Production Market Share (2018-2023)
Table 37. China Based Translational Regenerative Medicine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Translational Regenerative Medicine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Translational Regenerative Medicine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Translational Regenerative Medicine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Translational Regenerative Medicine Production Market Share (2018-2023)
Table 42. Rest of World Based Translational Regenerative Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Translational Regenerative Medicine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Translational Regenerative Medicine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Translational Regenerative Medicine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Translational Regenerative Medicine Production Market Share (2018-2023)
Table 47. World Translational Regenerative Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Translational Regenerative Medicine Production by Type (2018-2023) & (K Units)
Table 49. World Translational Regenerative Medicine Production by Type (2024-2029) & (K Units)
Table 50. World Translational Regenerative Medicine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Translational Regenerative Medicine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Translational Regenerative Medicine Average Price by Type (2018-2023) & (USD/Unit)
Table 53. World Translational Regenerative Medicine Average Price by Type (2024-2029) & (USD/Unit)
Table 54. World Translational Regenerative Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Translational Regenerative Medicine Production by Application (2018-2023) & (K Units)
Table 56. World Translational Regenerative Medicine Production by Application (2024-2029) & (K Units)
Table 57. World Translational Regenerative Medicine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Translational Regenerative Medicine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Translational Regenerative Medicine Average Price by Application (2018-2023) & (USD/Unit)
Table 60. World Translational Regenerative Medicine Average Price by Application (2024-2029) & (USD/Unit)
Table 61. Athersys Basic Information, Manufacturing Base and Competitors
Table 62. Athersys Major Business
Table 63. Athersys Translational Regenerative Medicine Product and Services
Table 64. Athersys Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Athersys Recent Developments/Updates
Table 66. Athersys Competitive Strengths & Weaknesses
Table 67. Avita Medical Basic Information, Manufacturing Base and Competitors
Table 68. Avita Medical Major Business
Table 69. Avita Medical Translational Regenerative Medicine Product and Services
Table 70. Avita Medical Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Avita Medical Recent Developments/Updates
Table 72. Avita Medical Competitive Strengths & Weaknesses
Table 73. AxoGen Basic Information, Manufacturing Base and Competitors
Table 74. AxoGen Major Business
Table 75. AxoGen Translational Regenerative Medicine Product and Services
Table 76. AxoGen Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AxoGen Recent Developments/Updates
Table 78. AxoGen Competitive Strengths & Weaknesses
Table 79. MEDIPOST Basic Information, Manufacturing Base and Competitors
Table 80. MEDIPOST Major Business
Table 81. MEDIPOST Translational Regenerative Medicine Product and Services
Table 82. MEDIPOST Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. MEDIPOST Recent Developments/Updates
Table 84. MEDIPOST Competitive Strengths & Weaknesses
Table 85. NuVasive Basic Information, Manufacturing Base and Competitors
Table 86. NuVasive Major Business
Table 87. NuVasive Translational Regenerative Medicine Product and Services
Table 88. NuVasive Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. NuVasive Recent Developments/Updates
Table 90. NuVasive Competitive Strengths & Weaknesses
Table 91. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Astellas Pharma Major Business
Table 93. Astellas Pharma Translational Regenerative Medicine Product and Services
Table 94. Astellas Pharma Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Astellas Pharma Recent Developments/Updates
Table 96. Astellas Pharma Competitive Strengths & Weaknesses
Table 97. Organogenesis Holdings Basic Information, Manufacturing Base and Competitors
Table 98. Organogenesis Holdings Major Business
Table 99. Organogenesis Holdings Translational Regenerative Medicine Product and Services
Table 100. Organogenesis Holdings Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Organogenesis Holdings Recent Developments/Updates
Table 102. Organogenesis Holdings Competitive Strengths & Weaknesses
Table 103. Osiris Therapeutics Basic Information, Manufacturing Base and Competitors
Table 104. Osiris Therapeutics Major Business
Table 105. Osiris Therapeutics Translational Regenerative Medicine Product and Services
Table 106. Osiris Therapeutics Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Osiris Therapeutics Recent Developments/Updates
Table 108. Osiris Therapeutics Competitive Strengths & Weaknesses
Table 109. Pharmicell Basic Information, Manufacturing Base and Competitors
Table 110. Pharmicell Major Business
Table 111. Pharmicell Translational Regenerative Medicine Product and Services
Table 112. Pharmicell Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Pharmicell Recent Developments/Updates
Table 114. Pharmicell Competitive Strengths & Weaknesses
Table 115. Regenerys Basic Information, Manufacturing Base and Competitors
Table 116. Regenerys Major Business
Table 117. Regenerys Translational Regenerative Medicine Product and Services
Table 118. Regenerys Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Regenerys Recent Developments/Updates
Table 120. Regenerys Competitive Strengths & Weaknesses
Table 121. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 122. Takeda Pharmaceutical Major Business
Table 123. Takeda Pharmaceutical Translational Regenerative Medicine Product and Services
Table 124. Takeda Pharmaceutical Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Takeda Pharmaceutical Recent Developments/Updates
Table 126. Takeda Pharmaceutical Competitive Strengths & Weaknesses
Table 127. uniQure Basic Information, Manufacturing Base and Competitors
Table 128. uniQure Major Business
Table 129. uniQure Translational Regenerative Medicine Product and Services
Table 130. uniQure Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. uniQure Recent Developments/Updates
Table 132. Vericel Basic Information, Manufacturing Base and Competitors
Table 133. Vericel Major Business
Table 134. Vericel Translational Regenerative Medicine Product and Services
Table 135. Vericel Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Translational Regenerative Medicine Upstream (Raw Materials)
Table 137. Translational Regenerative Medicine Typical Customers
Table 138. Translational Regenerative Medicine Typical Distributors
List of Figure
Figure 1. Translational Regenerative Medicine Picture
Figure 2. World Translational Regenerative Medicine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Translational Regenerative Medicine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Translational Regenerative Medicine Production (2018-2029) & (K Units)
Figure 5. World Translational Regenerative Medicine Average Price (2018-2029) & (USD/Unit)
Figure 6. World Translational Regenerative Medicine Production Value Market Share by Region (2018-2029)
Figure 7. World Translational Regenerative Medicine Production Market Share by Region (2018-2029)
Figure 8. North America Translational Regenerative Medicine Production (2018-2029) & (K Units)
Figure 9. Europe Translational Regenerative Medicine Production (2018-2029) & (K Units)
Figure 10. China Translational Regenerative Medicine Production (2018-2029) & (K Units)
Figure 11. Japan Translational Regenerative Medicine Production (2018-2029) & (K Units)
Figure 12. Translational Regenerative Medicine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Translational Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 15. World Translational Regenerative Medicine Consumption Market Share by Region (2018-2029)
Figure 16. United States Translational Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 17. China Translational Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 18. Europe Translational Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 19. Japan Translational Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Translational Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Translational Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 22. India Translational Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Translational Regenerative Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Translational Regenerative Medicine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Translational Regenerative Medicine Markets in 2022
Figure 26. United States VS China: Translational Regenerative Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Translational Regenerative Medicine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Translational Regenerative Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Translational Regenerative Medicine Production Market Share 2022
Figure 30. China Based Manufacturers Translational Regenerative Medicine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Translational Regenerative Medicine Production Market Share 2022
Figure 32. World Translational Regenerative Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Translational Regenerative Medicine Production Value Market Share by Type in 2022
Figure 34. Stem Cell Therapy
Figure 35. Tissue Engineering
Figure 36. Gene Therapy
Figure 37. World Translational Regenerative Medicine Production Market Share by Type (2018-2029)
Figure 38. World Translational Regenerative Medicine Production Value Market Share by Type (2018-2029)
Figure 39. World Translational Regenerative Medicine Average Price by Type (2018-2029) & (USD/Unit)
Figure 40. World Translational Regenerative Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Translational Regenerative Medicine Production Value Market Share by Application in 2022
Figure 42. Tissue Engineering Therapy
Figure 43. Wound Healing
Figure 44. Cartilage Repair
Figure 45. Other
Figure 46. World Translational Regenerative Medicine Production Market Share by Application (2018-2029)
Figure 47. World Translational Regenerative Medicine Production Value Market Share by Application (2018-2029)
Figure 48. World Translational Regenerative Medicine Average Price by Application (2018-2029) & (USD/Unit)
Figure 49. Translational Regenerative Medicine Industry Chain
Figure 50. Translational Regenerative Medicine Procurement Model
Figure 51. Translational Regenerative Medicine Sales Model
Figure 52. Translational Regenerative Medicine Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Translational Regenerative Medicine Supply, Demand and Key Producers, 2023-2029

Global Translational Regenerative Medicine Supply, Demand and Key Producers, 2023-2029

Page: 110

Published Date: 26 Mar 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

This report studies the global Translational Regenerative Medicine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Translational Regenerative Medicine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Translational Regenerative Medicine that contribute to its increasing demand across many markets.

The global Translational Regenerative Medicine market size is expected to reach $ 29460 million by 2029, rising at a market growth of 12.9% CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Translational Regenerative Medicine total production and demand, 2018-2029, (K Units)
Global Translational Regenerative Medicine total production value, 2018-2029, (USD Million)
Global Translational Regenerative Medicine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Translational Regenerative Medicine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Translational Regenerative Medicine domestic production, consumption, key domestic manufacturers and share
Global Translational Regenerative Medicine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Translational Regenerative Medicine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Translational Regenerative Medicine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Translational Regenerative Medicine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Athersys, Avita Medical, AxoGen, MEDIPOST, NuVasive, Astellas Pharma, Organogenesis Holdings, Osiris Therapeutics and Pharmicell, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Translational Regenerative Medicine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Translational Regenerative Medicine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Translational Regenerative Medicine Market, Segmentation by Type
Stem Cell Therapy
Tissue Engineering
Gene Therapy

Global Translational Regenerative Medicine Market, Segmentation by Application
Tissue Engineering Therapy
Wound Healing
Cartilage Repair
Other

Companies Profiled:
Athersys
Avita Medical
AxoGen
MEDIPOST
NuVasive
Astellas Pharma
Organogenesis Holdings
Osiris Therapeutics
Pharmicell
Regenerys
Takeda Pharmaceutical
uniQure
Vericel

Key Questions Answered
1. How big is the global Translational Regenerative Medicine market?
2. What is the demand of the global Translational Regenerative Medicine market?
3. What is the year over year growth of the global Translational Regenerative Medicine market?
4. What is the production and production value of the global Translational Regenerative Medicine market?
5. Who are the key producers in the global Translational Regenerative Medicine market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Translational Regenerative Medicine Introduction
1.2 World Translational Regenerative Medicine Supply & Forecast
1.2.1 World Translational Regenerative Medicine Production Value (2018 & 2022 & 2029)
1.2.2 World Translational Regenerative Medicine Production (2018-2029)
1.2.3 World Translational Regenerative Medicine Pricing Trends (2018-2029)
1.3 World Translational Regenerative Medicine Production by Region (Based on Production Site)
1.3.1 World Translational Regenerative Medicine Production Value by Region (2018-2029)
1.3.2 World Translational Regenerative Medicine Production by Region (2018-2029)
1.3.3 World Translational Regenerative Medicine Average Price by Region (2018-2029)
1.3.4 North America Translational Regenerative Medicine Production (2018-2029)
1.3.5 Europe Translational Regenerative Medicine Production (2018-2029)
1.3.6 China Translational Regenerative Medicine Production (2018-2029)
1.3.7 Japan Translational Regenerative Medicine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Translational Regenerative Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Translational Regenerative Medicine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Translational Regenerative Medicine Demand (2018-2029)
2.2 World Translational Regenerative Medicine Consumption by Region
2.2.1 World Translational Regenerative Medicine Consumption by Region (2018-2023)
2.2.2 World Translational Regenerative Medicine Consumption Forecast by Region (2024-2029)
2.3 United States Translational Regenerative Medicine Consumption (2018-2029)
2.4 China Translational Regenerative Medicine Consumption (2018-2029)
2.5 Europe Translational Regenerative Medicine Consumption (2018-2029)
2.6 Japan Translational Regenerative Medicine Consumption (2018-2029)
2.7 South Korea Translational Regenerative Medicine Consumption (2018-2029)
2.8 ASEAN Translational Regenerative Medicine Consumption (2018-2029)
2.9 India Translational Regenerative Medicine Consumption (2018-2029)

3 World Translational Regenerative Medicine Manufacturers Competitive Analysis
3.1 World Translational Regenerative Medicine Production Value by Manufacturer (2018-2023)
3.2 World Translational Regenerative Medicine Production by Manufacturer (2018-2023)
3.3 World Translational Regenerative Medicine Average Price by Manufacturer (2018-2023)
3.4 Translational Regenerative Medicine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Translational Regenerative Medicine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Translational Regenerative Medicine in 2022
3.5.3 Global Concentration Ratios (CR8) for Translational Regenerative Medicine in 2022
3.6 Translational Regenerative Medicine Market: Overall Company Footprint Analysis
3.6.1 Translational Regenerative Medicine Market: Region Footprint
3.6.2 Translational Regenerative Medicine Market: Company Product Type Footprint
3.6.3 Translational Regenerative Medicine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Translational Regenerative Medicine Production Value Comparison
4.1.1 United States VS China: Translational Regenerative Medicine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Translational Regenerative Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Translational Regenerative Medicine Production Comparison
4.2.1 United States VS China: Translational Regenerative Medicine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Translational Regenerative Medicine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Translational Regenerative Medicine Consumption Comparison
4.3.1 United States VS China: Translational Regenerative Medicine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Translational Regenerative Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Translational Regenerative Medicine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Translational Regenerative Medicine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Translational Regenerative Medicine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Translational Regenerative Medicine Production (2018-2023)
4.5 China Based Translational Regenerative Medicine Manufacturers and Market Share
4.5.1 China Based Translational Regenerative Medicine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Translational Regenerative Medicine Production Value (2018-2023)
4.5.3 China Based Manufacturers Translational Regenerative Medicine Production (2018-2023)
4.6 Rest of World Based Translational Regenerative Medicine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Translational Regenerative Medicine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Translational Regenerative Medicine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Translational Regenerative Medicine Production (2018-2023)

5 Market Analysis by Type
5.1 World Translational Regenerative Medicine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Stem Cell Therapy
5.2.2 Tissue Engineering
5.2.3 Gene Therapy
5.3 Market Segment by Type
5.3.1 World Translational Regenerative Medicine Production by Type (2018-2029)
5.3.2 World Translational Regenerative Medicine Production Value by Type (2018-2029)
5.3.3 World Translational Regenerative Medicine Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Translational Regenerative Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Tissue Engineering Therapy
6.2.2 Wound Healing
6.2.3 Cartilage Repair
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Translational Regenerative Medicine Production by Application (2018-2029)
6.3.2 World Translational Regenerative Medicine Production Value by Application (2018-2029)
6.3.3 World Translational Regenerative Medicine Average Price by Application (2018-2029)

7 Company Profiles
7.1 Athersys
7.1.1 Athersys Details
7.1.2 Athersys Major Business
7.1.3 Athersys Translational Regenerative Medicine Product and Services
7.1.4 Athersys Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Athersys Recent Developments/Updates
7.1.6 Athersys Competitive Strengths & Weaknesses
7.2 Avita Medical
7.2.1 Avita Medical Details
7.2.2 Avita Medical Major Business
7.2.3 Avita Medical Translational Regenerative Medicine Product and Services
7.2.4 Avita Medical Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Avita Medical Recent Developments/Updates
7.2.6 Avita Medical Competitive Strengths & Weaknesses
7.3 AxoGen
7.3.1 AxoGen Details
7.3.2 AxoGen Major Business
7.3.3 AxoGen Translational Regenerative Medicine Product and Services
7.3.4 AxoGen Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 AxoGen Recent Developments/Updates
7.3.6 AxoGen Competitive Strengths & Weaknesses
7.4 MEDIPOST
7.4.1 MEDIPOST Details
7.4.2 MEDIPOST Major Business
7.4.3 MEDIPOST Translational Regenerative Medicine Product and Services
7.4.4 MEDIPOST Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 MEDIPOST Recent Developments/Updates
7.4.6 MEDIPOST Competitive Strengths & Weaknesses
7.5 NuVasive
7.5.1 NuVasive Details
7.5.2 NuVasive Major Business
7.5.3 NuVasive Translational Regenerative Medicine Product and Services
7.5.4 NuVasive Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 NuVasive Recent Developments/Updates
7.5.6 NuVasive Competitive Strengths & Weaknesses
7.6 Astellas Pharma
7.6.1 Astellas Pharma Details
7.6.2 Astellas Pharma Major Business
7.6.3 Astellas Pharma Translational Regenerative Medicine Product and Services
7.6.4 Astellas Pharma Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Astellas Pharma Recent Developments/Updates
7.6.6 Astellas Pharma Competitive Strengths & Weaknesses
7.7 Organogenesis Holdings
7.7.1 Organogenesis Holdings Details
7.7.2 Organogenesis Holdings Major Business
7.7.3 Organogenesis Holdings Translational Regenerative Medicine Product and Services
7.7.4 Organogenesis Holdings Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Organogenesis Holdings Recent Developments/Updates
7.7.6 Organogenesis Holdings Competitive Strengths & Weaknesses
7.8 Osiris Therapeutics
7.8.1 Osiris Therapeutics Details
7.8.2 Osiris Therapeutics Major Business
7.8.3 Osiris Therapeutics Translational Regenerative Medicine Product and Services
7.8.4 Osiris Therapeutics Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Osiris Therapeutics Recent Developments/Updates
7.8.6 Osiris Therapeutics Competitive Strengths & Weaknesses
7.9 Pharmicell
7.9.1 Pharmicell Details
7.9.2 Pharmicell Major Business
7.9.3 Pharmicell Translational Regenerative Medicine Product and Services
7.9.4 Pharmicell Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Pharmicell Recent Developments/Updates
7.9.6 Pharmicell Competitive Strengths & Weaknesses
7.10 Regenerys
7.10.1 Regenerys Details
7.10.2 Regenerys Major Business
7.10.3 Regenerys Translational Regenerative Medicine Product and Services
7.10.4 Regenerys Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Regenerys Recent Developments/Updates
7.10.6 Regenerys Competitive Strengths & Weaknesses
7.11 Takeda Pharmaceutical
7.11.1 Takeda Pharmaceutical Details
7.11.2 Takeda Pharmaceutical Major Business
7.11.3 Takeda Pharmaceutical Translational Regenerative Medicine Product and Services
7.11.4 Takeda Pharmaceutical Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Takeda Pharmaceutical Recent Developments/Updates
7.11.6 Takeda Pharmaceutical Competitive Strengths & Weaknesses
7.12 uniQure
7.12.1 uniQure Details
7.12.2 uniQure Major Business
7.12.3 uniQure Translational Regenerative Medicine Product and Services
7.12.4 uniQure Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 uniQure Recent Developments/Updates
7.12.6 uniQure Competitive Strengths & Weaknesses
7.13 Vericel
7.13.1 Vericel Details
7.13.2 Vericel Major Business
7.13.3 Vericel Translational Regenerative Medicine Product and Services
7.13.4 Vericel Translational Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Vericel Recent Developments/Updates
7.13.6 Vericel Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Translational Regenerative Medicine Industry Chain
8.2 Translational Regenerative Medicine Upstream Analysis
8.2.1 Translational Regenerative Medicine Core Raw Materials
8.2.2 Main Manufacturers of Translational Regenerative Medicine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Translational Regenerative Medicine Production Mode
8.6 Translational Regenerative Medicine Procurement Model
8.7 Translational Regenerative Medicine Industry Sales Model and Sales Channels
8.7.1 Translational Regenerative Medicine Sales Model
8.7.2 Translational Regenerative Medicine Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Translational Regenerative Medicine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Translational Regenerative Medicine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Translational Regenerative Medicine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Translational Regenerative Medicine Production Value Market Share by Region (2018-2023)
Table 5. World Translational Regenerative Medicine Production Value Market Share by Region (2024-2029)
Table 6. World Translational Regenerative Medicine Production by Region (2018-2023) & (K Units)
Table 7. World Translational Regenerative Medicine Production by Region (2024-2029) & (K Units)
Table 8. World Translational Regenerative Medicine Production Market Share by Region (2018-2023)
Table 9. World Translational Regenerative Medicine Production Market Share by Region (2024-2029)
Table 10. World Translational Regenerative Medicine Average Price by Region (2018-2023) & (USD/Unit)
Table 11. World Translational Regenerative Medicine Average Price by Region (2024-2029) & (USD/Unit)
Table 12. Translational Regenerative Medicine Major Market Trends
Table 13. World Translational Regenerative Medicine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Translational Regenerative Medicine Consumption by Region (2018-2023) & (K Units)
Table 15. World Translational Regenerative Medicine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Translational Regenerative Medicine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Translational Regenerative Medicine Producers in 2022
Table 18. World Translational Regenerative Medicine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Translational Regenerative Medicine Producers in 2022
Table 20. World Translational Regenerative Medicine Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 21. Global Translational Regenerative Medicine Company Evaluation Quadrant
Table 22. World Translational Regenerative Medicine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Translational Regenerative Medicine Production Site of Key Manufacturer
Table 24. Translational Regenerative Medicine Market: Company Product Type Footprint
Table 25. Translational Regenerative Medicine Market: Company Product Application Footprint
Table 26. Translational Regenerative Medicine Competitive Factors
Table 27. Translational Regenerative Medicine New Entrant and Capacity Expansion Plans
Table 28. Translational Regenerative Medicine Mergers & Acquisitions Activity
Table 29. United States VS China Translational Regenerative Medicine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Translational Regenerative Medicine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Translational Regenerative Medicine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Translational Regenerative Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Translational Regenerative Medicine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Translational Regenerative Medicine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Translational Regenerative Medicine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Translational Regenerative Medicine Production Market Share (2018-2023)
Table 37. China Based Translational Regenerative Medicine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Translational Regenerative Medicine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Translational Regenerative Medicine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Translational Regenerative Medicine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Translational Regenerative Medicine Production Market Share (2018-2023)
Table 42. Rest of World Based Translational Regenerative Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Translational Regenerative Medicine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Translational Regenerative Medicine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Translational Regenerative Medicine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Translational Regenerative Medicine Production Market Share (2018-2023)
Table 47. World Translational Regenerative Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Translational Regenerative Medicine Production by Type (2018-2023) & (K Units)
Table 49. World Translational Regenerative Medicine Production by Type (2024-2029) & (K Units)
Table 50. World Translational Regenerative Medicine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Translational Regenerative Medicine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Translational Regenerative Medicine Average Price by Type (2018-2023) & (USD/Unit)
Table 53. World Translational Regenerative Medicine Average Price by Type (2024-2029) & (USD/Unit)
Table 54. World Translational Regenerative Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Translational Regenerative Medicine Production by Application (2018-2023) & (K Units)
Table 56. World Translational Regenerative Medicine Production by Application (2024-2029) & (K Units)
Table 57. World Translational Regenerative Medicine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Translational Regenerative Medicine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Translational Regenerative Medicine Average Price by Application (2018-2023) & (USD/Unit)
Table 60. World Translational Regenerative Medicine Average Price by Application (2024-2029) & (USD/Unit)
Table 61. Athersys Basic Information, Manufacturing Base and Competitors
Table 62. Athersys Major Business
Table 63. Athersys Translational Regenerative Medicine Product and Services
Table 64. Athersys Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Athersys Recent Developments/Updates
Table 66. Athersys Competitive Strengths & Weaknesses
Table 67. Avita Medical Basic Information, Manufacturing Base and Competitors
Table 68. Avita Medical Major Business
Table 69. Avita Medical Translational Regenerative Medicine Product and Services
Table 70. Avita Medical Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Avita Medical Recent Developments/Updates
Table 72. Avita Medical Competitive Strengths & Weaknesses
Table 73. AxoGen Basic Information, Manufacturing Base and Competitors
Table 74. AxoGen Major Business
Table 75. AxoGen Translational Regenerative Medicine Product and Services
Table 76. AxoGen Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AxoGen Recent Developments/Updates
Table 78. AxoGen Competitive Strengths & Weaknesses
Table 79. MEDIPOST Basic Information, Manufacturing Base and Competitors
Table 80. MEDIPOST Major Business
Table 81. MEDIPOST Translational Regenerative Medicine Product and Services
Table 82. MEDIPOST Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. MEDIPOST Recent Developments/Updates
Table 84. MEDIPOST Competitive Strengths & Weaknesses
Table 85. NuVasive Basic Information, Manufacturing Base and Competitors
Table 86. NuVasive Major Business
Table 87. NuVasive Translational Regenerative Medicine Product and Services
Table 88. NuVasive Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. NuVasive Recent Developments/Updates
Table 90. NuVasive Competitive Strengths & Weaknesses
Table 91. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Astellas Pharma Major Business
Table 93. Astellas Pharma Translational Regenerative Medicine Product and Services
Table 94. Astellas Pharma Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Astellas Pharma Recent Developments/Updates
Table 96. Astellas Pharma Competitive Strengths & Weaknesses
Table 97. Organogenesis Holdings Basic Information, Manufacturing Base and Competitors
Table 98. Organogenesis Holdings Major Business
Table 99. Organogenesis Holdings Translational Regenerative Medicine Product and Services
Table 100. Organogenesis Holdings Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Organogenesis Holdings Recent Developments/Updates
Table 102. Organogenesis Holdings Competitive Strengths & Weaknesses
Table 103. Osiris Therapeutics Basic Information, Manufacturing Base and Competitors
Table 104. Osiris Therapeutics Major Business
Table 105. Osiris Therapeutics Translational Regenerative Medicine Product and Services
Table 106. Osiris Therapeutics Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Osiris Therapeutics Recent Developments/Updates
Table 108. Osiris Therapeutics Competitive Strengths & Weaknesses
Table 109. Pharmicell Basic Information, Manufacturing Base and Competitors
Table 110. Pharmicell Major Business
Table 111. Pharmicell Translational Regenerative Medicine Product and Services
Table 112. Pharmicell Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Pharmicell Recent Developments/Updates
Table 114. Pharmicell Competitive Strengths & Weaknesses
Table 115. Regenerys Basic Information, Manufacturing Base and Competitors
Table 116. Regenerys Major Business
Table 117. Regenerys Translational Regenerative Medicine Product and Services
Table 118. Regenerys Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Regenerys Recent Developments/Updates
Table 120. Regenerys Competitive Strengths & Weaknesses
Table 121. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 122. Takeda Pharmaceutical Major Business
Table 123. Takeda Pharmaceutical Translational Regenerative Medicine Product and Services
Table 124. Takeda Pharmaceutical Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Takeda Pharmaceutical Recent Developments/Updates
Table 126. Takeda Pharmaceutical Competitive Strengths & Weaknesses
Table 127. uniQure Basic Information, Manufacturing Base and Competitors
Table 128. uniQure Major Business
Table 129. uniQure Translational Regenerative Medicine Product and Services
Table 130. uniQure Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. uniQure Recent Developments/Updates
Table 132. Vericel Basic Information, Manufacturing Base and Competitors
Table 133. Vericel Major Business
Table 134. Vericel Translational Regenerative Medicine Product and Services
Table 135. Vericel Translational Regenerative Medicine Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Translational Regenerative Medicine Upstream (Raw Materials)
Table 137. Translational Regenerative Medicine Typical Customers
Table 138. Translational Regenerative Medicine Typical Distributors
List of Figure
Figure 1. Translational Regenerative Medicine Picture
Figure 2. World Translational Regenerative Medicine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Translational Regenerative Medicine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Translational Regenerative Medicine Production (2018-2029) & (K Units)
Figure 5. World Translational Regenerative Medicine Average Price (2018-2029) & (USD/Unit)
Figure 6. World Translational Regenerative Medicine Production Value Market Share by Region (2018-2029)
Figure 7. World Translational Regenerative Medicine Production Market Share by Region (2018-2029)
Figure 8. North America Translational Regenerative Medicine Production (2018-2029) & (K Units)
Figure 9. Europe Translational Regenerative Medicine Production (2018-2029) & (K Units)
Figure 10. China Translational Regenerative Medicine Production (2018-2029) & (K Units)
Figure 11. Japan Translational Regenerative Medicine Production (2018-2029) & (K Units)
Figure 12. Translational Regenerative Medicine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Translational Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 15. World Translational Regenerative Medicine Consumption Market Share by Region (2018-2029)
Figure 16. United States Translational Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 17. China Translational Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 18. Europe Translational Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 19. Japan Translational Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Translational Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Translational Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 22. India Translational Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Translational Regenerative Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Translational Regenerative Medicine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Translational Regenerative Medicine Markets in 2022
Figure 26. United States VS China: Translational Regenerative Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Translational Regenerative Medicine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Translational Regenerative Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Translational Regenerative Medicine Production Market Share 2022
Figure 30. China Based Manufacturers Translational Regenerative Medicine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Translational Regenerative Medicine Production Market Share 2022
Figure 32. World Translational Regenerative Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Translational Regenerative Medicine Production Value Market Share by Type in 2022
Figure 34. Stem Cell Therapy
Figure 35. Tissue Engineering
Figure 36. Gene Therapy
Figure 37. World Translational Regenerative Medicine Production Market Share by Type (2018-2029)
Figure 38. World Translational Regenerative Medicine Production Value Market Share by Type (2018-2029)
Figure 39. World Translational Regenerative Medicine Average Price by Type (2018-2029) & (USD/Unit)
Figure 40. World Translational Regenerative Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Translational Regenerative Medicine Production Value Market Share by Application in 2022
Figure 42. Tissue Engineering Therapy
Figure 43. Wound Healing
Figure 44. Cartilage Repair
Figure 45. Other
Figure 46. World Translational Regenerative Medicine Production Market Share by Application (2018-2029)
Figure 47. World Translational Regenerative Medicine Production Value Market Share by Application (2018-2029)
Figure 48. World Translational Regenerative Medicine Average Price by Application (2018-2029) & (USD/Unit)
Figure 49. Translational Regenerative Medicine Industry Chain
Figure 50. Translational Regenerative Medicine Procurement Model
Figure 51. Translational Regenerative Medicine Sales Model
Figure 52. Translational Regenerative Medicine Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

jiaGou

Add To Cart

gouMai

Buy Now